Literature DB >> 1370236

Cutaneous responses to vasoactive intestinal polypeptide in chronic idiopathic urticaria.

C H Smith1, B Atkinson, R W Morris, N Hayes, J C Foreman, T H Lee.   

Abstract

Cutaneous wheal and flare responses to increasing concentrations of calcitonin gene-related peptide, substance P, neurokinin A, vasoactive intestinal polypeptide (VIP), compound 48/80, and phosphate-buffered saline were measured in 10 patients with chronic idiopathic urticaria and 10 healthy controls. A significant increase in VIP-induced wheal, but not flare or cutaneous blood flow, was seen in urticarial patients compared with controls (p less than 0.001). No significant differences in responses to other tested compounds were found between these groups. These data point to an increased sensitivity of microvasculature to VIP in patients with chronic idiopathic urticaria.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370236     DOI: 10.1016/0140-6736(92)91000-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

Review 1.  An overview of chronic urticaria.

Authors:  Vincent S Beltrani
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

Review 2.  Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases.

Authors:  Hariharan Subramanian; Kshitij Gupta; Hydar Ali
Journal:  J Allergy Clin Immunol       Date:  2016-07-20       Impact factor: 10.793

3.  Antipruritic effect of cold stimulation at the Quchi acupoint (LI11) in mice.

Authors:  Kao-Sung Tsai; Yung-Hsiang Chen; Huey-Yi Chen; Ein-Yiao Shen; Yu-Chen Lee; Jui-Lung Shen; San-Yuan Wu; Jaung-Geng Lin; Yi-Hung Chen; Wen-Chi Chen
Journal:  BMC Complement Altern Med       Date:  2014-09-19       Impact factor: 3.659

Review 4.  Unlocking the Non-IgE-Mediated Pseudo-Allergic Reaction Puzzle with Mas-Related G-Protein Coupled Receptor Member X2 (MRGPRX2).

Authors:  Mukesh Kumar; Karthi Duraisamy; Billy-Kwok-Chong Chow
Journal:  Cells       Date:  2021-04-27       Impact factor: 6.600

Review 5.  Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells.

Authors:  Hiroyuki Ogasawara; Masato Noguchi
Journal:  Cells       Date:  2021-10-27       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.